PEMT

Across TCGA pan-cancer cohorts, PEMT mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PEMT data layer compared with 24 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PEMT mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated PEMT expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

HNSC and LSCC are the cancer types where PEMT mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	0.296	0.812	.022	13	view →
LSCC	DFS	Tertile	III,IV	0.868	0.264	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PEMT–HNSC (DFS)

Open the HNSC breakdown →